GSK - GlaxoSmithKline plc

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
112.32B
Enterprise Value 3
111.59B
Trailing P/E
45.88
Forward P/E 1
14.73
PEG Ratio (5 yr expected) 1
4.04
Price/Sales (ttm)
N/A
Price/Book (mrq)
18.92
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) 0.41
52-Week Change 319.98%
S&P500 52-Week Change 318.19%
52 Week High 346.01
52 Week Low 336.87
50-Day Moving Average 344.38
200-Day Moving Average 341.75

Share Statistics

Avg Vol (3 month) 32.65M
Avg Vol (10 day) 33.83M
Shares Outstanding 52.49B
Float 2.45B
% Held by Insiders 10.01%
% Held by Institutions 111.00%
Shares Short (Nov 15, 2019) 47.55M
Short Ratio (Nov 15, 2019) 42.29
Short % of Float (Nov 15, 2019) 4N/A
Short % of Shares Outstanding (Nov 15, 2019) 40.25%
Shares Short (prior month Oct 15, 2019) 46.43M

Dividends & Splits

Forward Annual Dividend Rate 41.96
Forward Annual Dividend Yield 44.38%
Trailing Annual Dividend Rate 31.06
Trailing Annual Dividend Yield 32.34%
5 Year Average Dividend Yield 45.39
Payout Ratio 487.07%
Dividend Date 3Jan 9, 2020
Ex-Dividend Date 4Nov 14, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Nov 12, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 13.80%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)7.04%
Return on Equity (ttm)46.38%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)16.00%
Gross Profit (ttm)21.11B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly Earnings Growth (yoy)9.40%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)182.99
Current Ratio (mrq)0.82
Book Value Per Share (mrq)2.41

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A